FDA Drug recall D-0762-2022
Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured…
- FDA Drug
- Class III
- terminated
- Published 2022-04-13
On 2022-04-13 the FDA classified a Class III recall of Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured… by Macleods Pharma Usa, citing FAILED CONTENT UNIFORMITY SPECIFICATIONS.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0762-2022 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2022-03-10 |
| Published | 2022-04-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Macleods Pharma Usa |
| Distribution | US |
Product
Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.
Reason
FAILED CONTENT UNIFORMITY SPECIFICATIONS
Identifiers
| ndc | 33342-107-07 |
|---|---|
| ndc | 33342-107-49 |
| ndc | 33342-107-06 |
| ndc | 33342-108-07 |
| ndc | 33342-108-15 |
| ndc | 33342-108-06 |
| ndc | 33342-109-37 |
| ndc | 33342-109-50 |
| code_info | Lot #: BRD2001A, Exp 5/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0762-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.